MBMR Biolabs careers

We are developing targeted PET probes using antibody fragments and our proprietary bio-orthogonal ligation chemistry to introduce new F18-labeled probes that are safe, precise, and will be able to obtain information about 1) presence of tumors, 2) presence of metasteses, and 3) information about molecular composition of tumor, which will enable physicians to make treatment decisions that are personalized to each patient.